[DOI] [PMC free article] [PubMed] [Google Scholar] 97.Yip J.M.X., Chiang G.S.H., Lee I.C.J., Lehming-Teo R., Dai K., Dongol L., Wang L.Y.-T., Teo D., Seah G.T., Lehming N
Making a Provider-Guided Decision: Clinical Evaluation Framework Choosing between compounded semaglutide and tirzepatide requires structured clinical conversation with your healthcare provider
This is particularly helpful during drug shortages
If someone needs to stop taking the medication for any reason, they should talk with their doctor about how to stop treatment safely
Although both products contain recovery-focused ingredients, they were developed with different research priorities in mind